Check-Cap Ltd. Stock

Equities

CHEK

IL0011336851

Biotechnology & Medical Research

Market Closed - Nasdaq 04:30:00 2024-05-03 pm EDT 5-day change 1st Jan Change
2.2 USD -2.22% Intraday chart for Check-Cap Ltd. -3.72% +5.77%
Sales 2021 - Sales 2022 - Capitalization 12.81M
Net income 2021 -17M Net income 2022 -19M EV / Sales 2021 -
Net cash position 2021 50.43M Net cash position 2022 40.74M EV / Sales 2022 -
P/E ratio 2021
-3.25 x
P/E ratio 2022
-0.65 x
Employees 85
Yield 2021 *
-
Yield 2022
-
Free-Float 74.84%
More Fundamentals * Assessed data
Dynamic Chart
1 day-2.22%
1 week-3.72%
Current month-1.12%
1 month-17.60%
3 months+3.29%
6 months-38.55%
Current year+5.77%
More quotes
1 week
2.16
Extreme 2.155
2.30
1 month
2.12
Extreme 2.12
2.74
Current year
1.78
Extreme 1.78
3.45
1 year
1.30
Extreme 1.3
4.63
3 years
1.22
Extreme 1.22
38.18
5 years
1.22
Extreme 1.22
89.80
10 years
1.22
Extreme 1.22
1 427.98
More quotes
Managers TitleAgeSince
Founder 63 04-12-31
Chief Tech/Sci/R&D Officer - 21-08-31
Chief Tech/Sci/R&D Officer 52 11-12-31
Members of the board TitleAgeSince
Director/Board Member 71 15-03-14
Director/Board Member 64 15-04-30
Founder 63 04-12-31
More insiders
Date Price Change Volume
24-05-03 2.2 -2.22% 6,648
24-05-02 2.25 -2.17% 16,707
24-05-01 2.3 +3.37% 5,572
24-04-30 2.225 +0.23% 17,160
24-04-29 2.22 -2.84% 9,098

Delayed Quote Nasdaq, May 03, 2024 at 04:30 pm EDT

More quotes
Check Cap Ltd is an Israel-based clinical-stage medical diagnostics company. Check Cap Ltd develops C-Scan, patient-friendly preparation-free test designed to detect polyps before they may transform into cancer to enable early intervention and cancer prevention. It's capsule-based screening technology aims to increase screening adherence worldwide. The system utilizes ultra-low-dose X- rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities. C-Scan is non-invasive capsule that is propelled through the gastrointestinal tract by natural motility. C-Scan is comprised of three main components: C-Scan Cap, an ingestible X-ray scanning capsule; C-Scan Track, three miniaturized patches worn on the patient’s back for integrated positioning, control and data recording; and C-Scan View, a proprietary software to process and represent 2D and 3D maps of the inner surface of the colon.
More about the company